© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Emerging Markets

Top section

Data

More articles

More articles

More articles

  • Chaoju Eye Care Holdings is gauging investor appetite for a HK$1.81bn ($233m) listing on the Hong Kong Stock Exchange, becoming the latest healthcare related company to seek an IPO.
  • I have used Covid-19 as an excuse to avoid some unwanted social occasions over the last year or so, but a friend of mind has taken his Covid isolation to a new level.
  • Chinese technology companies are flocking back to the US for IPOs after months of poor market conditions and the regulatory crackdown on the sector brought deal flow to a near halt. There is more on the way too, as issuers look to wrap up deals before the summer slowdown. Jonathan Breen reports.
  • Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.
  • Beijing Construction Engineering Group sold a tightly priced $600m bond by getting a rating for the first time, a move that made a ‘huge difference’ to the company’s fundraising.
  • The offshore renminbi (CNH) bond market saw a jump in action this week, with three issuers taking advantage of favourable issuing conditions to roll out deals. Addison Gong reports.